MGI Partners with NGeneBio to Advance Precision Medicine
August 22, 2023
SEOUL, South Korea -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access of NGeneBio's cancer testing products globally. This strategic partnership will enable the integration of NGeneBio's advanced diagnostic [...]
August 22, 2023
New collaboration aims to broaden access to nanopore sequencing technology to accelerate patient diagnosis and genomic research Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services in healthcare and life sciences, has [...]
Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
August 21, 2023
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has received a letter from the staff of the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq's minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing [...]
William P. Donnelly Appointed to Quanterix’s Board of Directors
August 21, 2023
BILLERICA, Mass. -- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it appointed William (Bill) P. Donnelly to its Board of Directors. Mr. Donnelly brings many years of senior leadership experience in the life science tools industry, including 21 years at Mettler-Toledo International Inc., [...]
Maria Forss is appointed new President and CEO of BICO Group AB
August 21, 2023
BICO Group AB (publ) announces that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as President and CEO of BICO Group. Maria Forss has been appointed new President and CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss has been appointed new President [...]
Scale Biosciences and Basepair to Democratize Single Cell Sequencing Data Analysis
August 21, 2023
SAN DIEGO -- Scale Biosciences, a pioneer in single-cell sequencing technology, today announced a new collaboration with Basepair to provide point and click bioinformatic analysis of single-cell data produced with its patented and disruptive combinatorial indexing technology. As a result of this collaboration, scientists will be able to access Scale Biosciences’ optimized bioinformatics pipeline through [...]
New management team at m-u-t GmbH
August 21, 2023
An interim report after 100 days. After many successful years in his double function as board member of the Nynomic Group and managing director (CEO) of the subsidiary m-u-t GmbH, Fabian Peters now dedicates himself exclusively to the rapidly growing Nynomic Group. Since March 1, 2023, Axel Witte (CEO) and Christian Felsch (CTO) have jointly [...]
August 18, 2023
NEW LONDON, N.H.-- Orange Photonics, a pioneer in revolutionizing HPLC technology, is proud to announce that the US Food and Drug Administration (FDA) has selected the LightLab 3 High Sensitivity (HS) Cannabis Analyzer to play a pivotal role in its efforts to regulate the national cannabis industry. This move comes after numerous international and state regulatory agencies [...]
Sampled Named a Service Provider for Olink Proteomics
August 18, 2023
Sampled is now an Olink Service Provider Piscataway, NJ – Sampled1,The Global Integrated Analytical Biorepository, today announced that it has been named a Service Provider for Olink® Proteomics, a leader in Proteomics technology. As a service provider of Olink® Explore technology, Sampled now offers high throughput proteomics services for precise protein biomarker discovery. The Olink Explore [...]
August 17, 2023
Financing led by M Ventures, with participation from existing investors ARCH Venture Partners, Illumina Ventures, OMX Ventures, +ND Capital, and Longwall Ventures Novel single-cell platform allows users to control and profile massively parallel and sequential droplet- based assays, with end-to-end tracking and live cell recovery for downstream applications Funding will accelerate company growth and expansion [...]

